top of page

Hematological Biobank
A national biobank
Our goal is a better future for patients with haematological diseases
The Hematological Biobank collects biological samples and related data from patients with haematological diseases and grants access to samples and data for research use in accordance with predefined criteria and principles.
The goal of the Hematological Biobank is to develop new methods for the diagnosis and treatment of haematological diseases and to improve the prognosis of patients.
The Hematological Biobank is owned by the Finnish Hematology Association (SHY) and the Institute for Molecular Medicine Finland (FIMM), which operates as part of the University of Helsinki.
The biobank operates on a non-profit basis.
More Information
bottom of page
